Neutrophil / Iymphocyte ratio, platelet / Iymphocyte ratio, mean platelet volume and C-reactive protein values in psoriatic arthritis patients
Neutrophil / Iymphocyte ratio, platelet / Iymphocyte ratio, mean platelet volume and C-reactive protein values in psoriatic arthritis patients
Aim: Studies have shown that neutrophil / lymphocyte ratio (NLR), platelet / lymphocyte ratio(PLR), mean platelet volume(MPV) andC-reactive protein(CRP) are higher in psoriatic arthritis patients than in the control group. In this study, NLR, PLR and MPV values ofpatients with psoriatic arthritis were calculated and if these parameters were related to CRP levels.Material and Methods: 74 psoriatic arthritis patients and 77 healthy controls without any systemic, infectious and autoimmunediseases were included in the study. Patients were divided into two groups according to their CRP values: normal (0-0.5 mg / dl) andhigh (> 0.5 mg / dl)Results: NLR, MPV and CRP values in the patient group were significantly higher than the control group. PLR value in the patientgroup was higher than the control group but the difference between them was not statistically significant. There was a statisticallysignificant relationship between CRP and NLR and MPV values in psoriatic arthritis patients.Conclusion: Since NLR and MPV were significantly higher in psoriatic arthritis patients than in the control group and there was astatistically significant relationship with CRP elevation, it was thought that they were appropriate parameters to show inflammationin patients with psoriatic arthritis.
___
- 1. An İ. tatuaj komplikasyonu olarak tip 2 köbner fenomeni
gelişen psoriasisli bir olgu. Dermatoz 2018;9:1809204.
- 2. Kılıc S, Resorlu H, Işik S, et al. Association between mean
platelet volume and disease severity in patients with
psoriasis and psoriatic arthritis. Postepy Dermatol Alergol
2017;34:126-30.
- 3. Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to
lymphocyte ratio and platelet to lymphocyte ratio in Korean
patients with psoriasis vulgaris and psoriatic arthritis. J
Derma-tol 2016;43:305-10.
- 4. Asahina A, Kubo N, Umezawa Y, et al. Neutrophil–
lymphocyte ratio, platelet–lymphocyte ratio and mean
platelet volume in Japanese patients with psoriasis and
psoriatic arthritis: Response to therapy with biologics. J
Dermatol 2017;44:1112-21.
- 5. Kerschbaumer A, Fenzl KH, Erlacher L, et al. An overview
of psoriatic arthritis - epidemiology, clinical features,
pathophysiology and novel treatment targets. Wien Klin
Wochenschr 2016;128:791-5.
- 6. Kasapkara HA, Aslan AN, Ayhan H, et al. Higer neutrophil
to lymphocyte ratio is related to a lower ejectionfraction in
bicuspid aortic valve patients. Turk J Med Sci. 2016;46:1144-
50.
- 7. Özgehan G, Kahramanca Ş, Kaya İO, et al. Neutrophillymphocyte
ratio as a predictive factor for tumor staging in
colorectal cancer. Turk J Med Sci 2014;44:365-8.
- 8. Kılıç S, Işık S, Hiz MM, et al. The ischemia modified albumin
and mean platelet volume levels in patients with Behçet’s
disease. Postepy Dermatol Alergol 2016;33:345-8.
- 9. Sahpaz P, Ulutas KT. İnsülin veya oral anti diyabetik ilaç
alan tip 2 diyabetli hastalarda ortalama trombosit hacminin
değerlendirilmesi. Dicle Tıp Dergisi 2015;42:399-403.
- 10. Pamuk GE, Nuri Pamuk O, Orum H, et al. Elevated plateletmonocyte
complexes in patients with psoriatic arthritis.
Platelets 2009;20:493-7.
- 11. Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte
ratio beter predicts inflammation than neutrophil-tolymphocyte
ratio in end-stage renal disease patients.
Hemodial Int 2013;17:391-6.
- 12. Kim DS, Lee J, Kim SH, et al. Mean platelet volume is
elevated in patients with psoriasis vulgar-is. Yonsei Med J
2015;56:712-8.
- 13. Canpolat F, Akpinar H, Eskioğlu F. Mean platelet volume
in psoriasis and psoriatic arthritis. Clin Rheumatol
2010;29:325-8.
- 14. Taylor W, Gladman D, Helliwell P, et al. Classification criteria
for psoriatic arthritis: development of new criteria from a
large international study. Arthritis Rheum 2006;54:2665-73.
- 15. Balta S, Cakar M, Demirkol S, et al. Higher neutrophil to lymphocyte ratio in patients with meta-bolic syndrome. Clin
Appl Thromb Hemost 2013;19:579.
- 16. An I, Ucmak D, Ozturk M. Evaluation of neutrophil-tolymphocyte
ratio, platelet-tolymphocyte ratio and mean
platelet volume in patients with lichen planus. Ann Med Res
2019;26:161-4.
- 17. An I, Ucmak D. Evaluation of neutrophil-to-lymphocyte ratio,
platelet-to-lymphocyte ratio, mean platelet volume, and
C-reactive protein in patients with psoriasis vulgaris. Dicle
Med J 2018;45:327-34.
- 18. Cemil BC, Ataş H. Psoriasis Hastalarında Biyolojik Tedavinin
Sistemik İnflamatuvar Belirteçler ve Plateletcrit Üzerine
Etkisi. Dicle Tıp Dergisi.2016;43:477-83.
- 19. Unal M, Küçük A, Ünal GÜ, et al. Psoriasiste ortalama
trombosit hacmi, nötrofil/lenfosit oranı ve trombosit/
lenfosit oranı. Turkderm 2015;49:112-6.
- 20. Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular
events in patients with psoriatic arthritis, psoriasis and
rheumatoid arthritis: a population-based cohort study. Ann
Rheum Dis 2015;74:326-32.
- 21. Prey S, Paul C, Bronsard V, et al. Assessment of risk of
psoriatic arthritis in patients with plaque psoriasis: a
systematic review of the literature. J Eur Acad Dermatol
Venereol 2010;24:31-5.
- 22. Uslu AU, Küçük A, Sahin A, et al. Two new inflammatory
markers associated with disease activ-ity score-28 in
patients with rheumatoid arthritis: neutrophil-lymphocyte
ratio and platelet-lymphocyte ratio. Int J Rheum Dis
2015;18:731-5.
- 23. Katoh N. Platelets as versatile regulators of cutaneous
inflammation. J Dermatol Sci 2009;53:89-95.
- 24. Schottelius AJ, Moldawer LL, Dinarello CA, et al. Biology of
tumor necrosis factor-alpha impli-cation for psoriasis. Exp
Dermatol 2004;13:193-222.
- 25. Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and
leucocyte activation in psoriasis vul-garis according to
severity and therapy. JEADV 2010;24:789-96.
- 26. Beygi S, Lajevardi V, Abedini R. C-reactive protein in
psoriasis: a review of the literature JEADV 2014;28:700-11.
- 27. Asahina A, Umezawa Y, Yanaba K, et al. Serum C-reactive
protein levels in Japanese patients with psoriasis and
psoriatic arthritis: long-term differential effects of biologics.
J Dermatol 2016;43:779-84.
Ann Med Res 2019;26(5):894-8
898